TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W, Matsubara A.
Sekino Y, et al. Among authors: shiota m.
Int J Mol Sci. 2019 Aug 13;20(16):3936. doi: 10.3390/ijms20163936.
Int J Mol Sci. 2019.
PMID: 31412591
Free PMC article.